Table 2.
Variables | normal control (n = 20) | COPD with normal BMD (n = 30) | COPD with low BMD (n = 30) |
---|---|---|---|
IL-1β (fg/ml) | 122.21 ± 35.14 | 186.83 ± 104.87† | 192.94 ± 115.82† |
IL-6(fg/ml) | 354.37 ± 83.14 | 421.52 ± 125.78† | 483.73 ± 110.38†‡ |
TNF-α (fg/ml) | 193.09 ± 81.20 | 261.28 ± 96.09† | 324.37 ± 141.29†‡ |
OPG(pg/ml) | 236.50 ± 38.76 | 240.43 ± 65.77 | 257.97 ± 86.80 |
RANK(pg/ml) | 82.28 ± 29.76 | 73.90 ± 50.41 | 2.24 ± 0.80 †‡ |
Data are mean (SD) unless otherwise stated.
†p < 0.05 compared with the normal control group.
‡p < 0.05 compared with the COPD with normal BMD group
COPD: chronic obstructive pulmonary disease, BMD: bone mineral density, IL: interleukin, TNF-α:tumor necrosis factor α, OPG: osteoprotegerin, RANK: receptor activator of NF-κB, RANKL: RANK ligand